The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens. Experts say the new injectable, which works ...

Front desk of Ward 86, located inside of Zuckerberg San Francisco General Hospital. Photo by Julie Chang on Nov. 15, 2018. Sign up below to get Mission Local’s free newsletter, a daily digest of news ...

Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...

The Department of Health said the decision reflects its mandate to ensure that all citizens have access to safe, effective, ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, ...

South Africa takes the lead in HIV prevention with a groundbreaking twice-a-year injection being added to the Essential Medicines List.

APPLIN: After nearly 20 years in HIV care, I’ve seen that HIV follows people through every season of life. When life is stable, patients stay in care and maintain suppression, but when challenges ...

THURSDAY, Nov. 28, 2024 (HealthDay News) -- People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themselves. But researchers have come up with a ...

An injection to prevent HIV which is being offered in Great Britain will also be rolled out in Northern Ireland, it has been confirmed. The long-acting cabotegravir (CAB-LA) jab, which is administered ...

The role of and indication for long-acting injectables is highlighted as a treatment approach for HIV. Adam C. Welch, PharmD, MBA: An evolving space is long-acting injectables. It sounds great: 1 ...

A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection against HIV, tapping into a critical window in early life that could reshape the ...